Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer

Fig. 5

Biodistribution and antitumor activity of CLip-PC@CO-LC NPs. a Biodistribution of free DiR and CLip-PC@LC-DiR in A549 cell tumor-bearing nude BALB/c mice at 1, 3, 6, 12, and 24 h after administration. b Fluorescence distribution images of tumors and major organs after intravenously injecting free DiR and CLip-PC@LC-DiR NPs in mice tails. c Tumor growth curves of A549 tumor-bearing mice after receiving various treatments (n = 6). d Body weights of the A549 tumor-bearing mice after receiving various treatments. e The tumor weights of the A549 tumors excised from all groups after different treatments. Data are expressed as the mean ± standard deviation (SD; n = 6). f Mice survival rates after different treatments (n = 6)

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us